Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene

scientific article published in September 2004

Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00535-003-1409-Z
P698PubMed publication ID15565413

P2093author name stringTakakazu Higuchi
Tadashi Matsumoto
Masahiko Yamaguchi
Genshu Tate
P433issue9
P921main subjectimatinibQ177094
patientQ181600
P304page(s)904-905
P577publication date2004-09-01
P1433published inJournal of GastroenterologyQ15764399
P1476titleSecondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene
P478volume39

Reverse relations

cites work (P2860)
Q38987052Crohn's disease presenting as a ceco-urachal fistula.
Q51751891Laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors: report of a case.
Q39281806Medical Versus Interventional Treatment of Intra-Abdominal Abscess in Patients With Crohn Disease.
Q36171733Methods to avoid infections in patients with inflammatory bowel disease
Q36632245Point mutations of protein kinases and individualised cancer therapy
Q50689278Risk and management of intra-abdominal abscess in Crohn's disease treated with infliximab.
Q27000186Surgery and diagnostic imaging in abdominal Crohn's disease.
Q38085431Variation in management of intra-abdominal abscesses in children with Crohn's disease

Search more.